Developer docs
API playgroundTry for free, no card

Search company profiles

Mercodia

Full company profile

uuid000lb3v

Namestring
Mercodia
Legal namestring
Mercodia Aktiebolag
Websiteurl
mercodia.com
Company typeenum
Private
Founded yearint
1991
Descriptiontext

Mercodia is a privately held Swedish biotech company founded in 1991 in Uppsala by Erling Holmlund, formerly of Pharmacia Diagnostics. The company develops and manufactures gold-standard immunoassays—primarily ELISA kits and MBeads bead-based assays—for the quantification of cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, and the more recently launched HNL Homodimer for sepsis research. Its portfolio spans human assays and species-specific kits for mouse, rat, bovine, canine, equine, ovine, and porcine models, complemented by proprietary control and buffer products, and is supported by patented biological assets such as the 4E6 monoclonal antibody underpinning the Oxidized LDL ELISA.

The company operates three revenue streams: (1) immunoassay kit sales distributed across 76+ countries via direct website sales, regional sales managers, and authorized distributors; (2) GLP-compliant bioanalytical services for preclinical and clinical studies—including PK/PD analysis, biomarker analysis across 500+ analytes, assay development, and immunogenicity testing; and (3) ISO 13485:2016 / MDSAP-certified contract manufacturing of reagents, buffers, and coated plates for life science partners. Bioanalytical services are delivered from labs in Uppsala, Sweden and Winston-Salem, North Carolina (established 2023), supporting FDA, EMA, and ICH regulatory workflows for pharmaceutical and biotechnology clients developing diabetes, obesity, and cardiovascular therapies.

Mercodia serves a horizontally segmented customer base spanning pharmaceutical/biotech drug developers, academic and research institutions, and veterinary diagnostics customers, with 9,997+ peer-reviewed publications citing its products and 190+ completed bioanalytical projects. The business has grown approximately 70% over the past three years and 33% in 2024, earning the Di Gasell business growth award from Dagens industri six consecutive times, and is led by CEO Jörgen Dahlström alongside CFO Mats Lundin, CCO Torben Thölix, and COO Jonas Hermansson.

Short descriptiontext

Mercodia is a Swedish biotech founded in 1991 that develops gold-standard immunoassays and provides GLP-compliant bioanalytical services for cardiometabolic drug development, serving pharmaceutical, biotech, and academic customers across 76+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersUppsala, Sweden
HQ citystring
Uppsala
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
immunoassay kits, bioanalytical services, cardiacmetabolic biomarkers, ELISA assays, contract manufacturing
Industry5 codes
PRIMARYHLAGAEAG
Bioanalytical & PK/PD Sample Analysis (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAHAAAA
Clinical Chemistry & Immunoassay Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical Laboratories621511
  • Analytical Laboratory Instrument Manufacturing334516
SIC code3 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
  • Laboratory Analytical Instruments3826
Product category
Immunoassay Kits
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Immunoassay Product Sales
TypeOne Time License
Description

Sale of gold-standard ELISA kits and MBeads assays for cardiometabolic research. Products include insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, MPO, HNL Homodimer, and species-specific assays (mouse, rat, bovine, canine, equine, porcine, ovine).

mercodia.com
2Bioanalytical Services
TypeProfessional Services
Description

Contract research services for preclinical and clinical studies including PK/PD analysis, biomarker analysis, assay development, immunogenicity testing. Services provided from GLP-compliant laboratories in Sweden and USA.

mercodia.com
3Contract Manufacturing
TypeLicensing Royalties
Description

Custom production of assay kits, buffers, coated plates, and key components for life science industry partners. Manufacturing follows ISO 13485:2016 and MDSAP standards.

mercodia.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Standard ELISA kits - single and 10-pack formats
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Products sold as kits (1x96 wells or 10x96 wells). HNL Homodimer launch offer: 25% off first order with promo code TRYHNL25 until March 31, 2026.

mercodia.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Mercodia develops, manufactures, and sells gold-standard immunoassay kits (ELISA and MBeads platforms) for quantitative measurement of cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, MPO, and HNL Homodimer across human and animal matrices. The company also provides GLP-compliant bioanalytical services (PK/PD, biomarker analysis, assay development, immunogenicity testing) from laboratories in Sweden and the US, and offers contract manufacturing of assay kits and components under ISO 13485:2016 and MDSAP standards.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 33% revenue growth in 2024, 70% total growth over 3 years
+3 more records
Product overview1 text field

Mercodia offers a comprehensive portfolio of gold-standard immunoassays for cardiometabolic and metabolic disease research, combined with expert bioanalytical services and contract manufacturing solutions. The product portfolio includes over 40 distinct ELISA kits and MBeads assays spanning human, rat/mouse, and larger animal (bovine, canine, equine, ovine, porcine) applications, focused on cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, glicentin, proinsulin, oxidized LDL, Lp(a), MPO, and HNL Homodimer. These are complemented by control products (Diabetes Antigen Controls, GLP-1 Control, Glucagon Control, Animal Insulin Control) and supplement products (Diabetes Sample Buffer). The services division provides GLP-compliant bioanalytical services including PK/PD analysis, biomarker analysis (500+ biomarkers), assay development, immunogenicity testing, and contract manufacturing of assay kits, buffers, and coated plates under ISO 13485:2016 and MDSAP standards.

Product and service24 records
1C-peptide ELISA
CategoryImmunoassay Kit
Description

High-quality immunoassay for specific quantification of human C-peptide in serum, plasma, or urine. CE/IVD labeled on selected markets. Measurement range: 100-4000 pmol/L.

2Ultrasensitive C-peptide ELISA
CategoryImmunoassay Kit
Description

High-quality immunoassay for specific quantification of low levels of human C-peptide in serum, plasma, or urine. Measurement range: 5-280 pmol/L with detection limit below 2.5 pmol/L.

3Total GIP ELISA
CategoryImmunoassay Kit
Description

Chemiluminescent immunoassay for quantitative determination of total GIP (glucose-dependent insulinotropic polypeptide) in human samples. Measures both active GIP(1-42) and inactive isoform GIP(3-42).

4Glicentin ELISA
CategoryImmunoassay Kit
Description

Highly specific, sensitive immunoassay for determination of human glicentin in serum, plasma, and cell culture media. No cross-reactivity to circulating proglucagon-derived gut peptides.

5Total GLP-1 ELISA
CategoryImmunoassay Kit
Description

Chemiluminescent immunoassay for quantitative determination of amidated glucagon-like-peptide-1 (GLP-1) in human plasma and serum. Validated according to CLSI, FDA, and EMA guidelines.

6Glucagon ELISA
CategoryImmunoassay Kit
Description

CE/IVD-labeled highly specific and sensitive immunoassay for measuring glucagon in plasma and serum. No cross-reactivity to glicentin, proglucagon 1-16, and glucagon 3-29.

7HNL Homodimer ELISA
CategoryImmunoassay Kit
Description

Immunoassay for specific quantification of human homodimeric Human Neutrophil Lipocalin (HNL) in EDTA plasma. Biomarker for sepsis monitoring and antibiotic response research with superior specificity over CRP and PCT.

8Insulin (Total) MBeads Assay
CategoryImmunoassay Kit
Description

High-throughput tool enabling high specificity results from small sample volumes. For measurement of insulin in conditioned media from perifusion experiments or in vitro cultures. Kit format: 5 x 96 wells or 1 x 384 wells.

9Ultrasensitive Insulin ELISA
CategoryImmunoassay Kit
Description

High quality immunoassay for specific quantification of low levels of human insulin in serum or plasma. Measurement range: 0.15-20 mU/L. Calibrated against 1st International Reference Preparation 66/304.

10Insulin ELISA
CategoryImmunoassay Kit
Description

High-quality ELISA for specific measurement of human insulin in serum or plasma. Measurement range: 3-200 mU/L. Available in 1-pack and 10-pack formats.

11Insulin MBeads Assay (Human)
CategoryImmunoassay Kit
Description

High-throughput tool for highly specific insulin measurement from minimal sample volumes (10 µL). Optimized for detecting human insulin in serum, conditioned media, cell lysates, and homogenates.

12Iso-Insulin ELISA
CategoryImmunoassay Kit
Description

Quantitative determination of human insulin in serum or plasma, measuring both endogenous and exogenous insulin including common and non-commercially available insulin analogues.

13Lispro NL-ELISA
CategoryImmunoassay Kit
Description

Chemiluminescent immunoassay for quantitative determination of insulin lispro. Optimized for pharma use with no cross-reactivity to endogenous insulin or other insulin analogs. Validated for human and pig samples.

14Lp(a) ELISA
CategoryImmunoassay Kit
Description

Solid phase two-site enzyme immunoassay for quantitative determination of human Lipoprotein(a) in serum or plasma. Calibrated against validated Lp(a) preparation.

15MPO ELISA
CategoryImmunoassay Kit
Description

High quality enzyme immunoassay for quantification of human myeloperoxidase (MPO) in serum and plasma. Marker for airway inflammation, atherosclerosis, and cardiovascular disease risk.

16Oxidized LDL ELISA
CategoryImmunoassay Kit
Description

Unique sandwich ELISA based on proprietary mouse monoclonal antibody 4E6 for quantification of oxidized low-density lipoproteins. Central biomarker in atherosclerosis and cardiovascular disease.

17Proinsulin ELISA
CategoryImmunoassay Kit
Description

Method for quantitative determination of human proinsulin in serum or plasma. Highly specific with no cross-reactivity to human insulin or C-peptide. Calibrated against IRR 84/611.

18Mouse Insulin ELISA
CategoryImmunoassay Kit
Description

Easy-to-use assay for mouse insulin with highly specific monoclonal antibodies. Measurement range: 0.2-6.5 µg/L. Low sample volume (10 µL with 5 µL protocol available).

19Bioanalytical Services
CategoryService
Description

Tailored bioanalytical services for preclinical to clinical studies, primarily for biologics/large molecules, biosimilars, peptides, and gene therapy products. Includes PK & PD analysis, biomarker analysis, assay development, and immunogenicity testing from GLP-compliant laboratories in Sweden and the US.

20Biomarker Analysis
CategoryService
Description

Biomarker analysis services covering 500+ biomarkers for preclinical and clinical studies in cardiometabolic disease research.

21PK & PD Analysis
CategoryService
Description

Pharmacokinetics and pharmacodynamics analysis services for drug development, providing data to support dosing and efficacy decisions.

22Immunogenicity Testing
CategoryService
Description

Immunogenicity testing services to assess immune responses to biologics and therapeutics, supporting regulatory submissions for large molecule drugs.

23Assay Development & Optimization
CategoryService
Description

Custom assay development and optimization services for specific biomarker and therapeutic analysis needs, leveraging 30+ years of immunoassay expertise.

24Contract Manufacturing
CategoryService
Description

Custom production of assay kits, buffers, coated plates, and key components for the life science industry. Manufacturing validated according to ISO 13485:2016 and MDSAP standards.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Celtic Molecular Diagnostics
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-11
Description

New distribution partnership covering Botswana, Namibia, South Africa, Uganda, and Zambia. Celtic Molecular Diagnostics is a well-established supplier of high-quality laboratory solutions in the region, ensuring improved local availability of Mercodia's immunoassays and responsive customer support.

mercodia.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-24
Description

Mercodia and Attana entered a strategic collaboration to advance bioanalysis. The partnership combines Mercodia's bioanalytical expertise with Attana's technology to develop next-generation solutions for preclinical drug development.

3Lablytica
Strategic tierMinorTypeOthers
Description

Listed as partner on services page with logo display.

mercodia.com
Strategic tierMinorTypeOthers
Description

Listed as partner on services page with logo display.

5CTC
Strategic tierMinorTypeOthers
Description

Listed as partner on services page with logo display.

mercodia.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Charles River is a large CRO providing preclinical and clinical bioanalytical services, including ligand binding assays and immunogenicity testing. It competes with Mercodia's bioanalytical services arm from a broader portfolio perspective.

TypeDirect peer
Description

Meso Scale Diagnostics (MSD) is a direct competitor in high-sensitivity immunoassay platforms for biomarker analysis, serving pharmaceutical, biotech, and academic researchers with multiplexed electrochemiluminescence assays — closely comparable technology and customer base to Mercodia's ELISA and MBeads offerings.

TypeDirect peer
Description

Bio-Techne is a major life sciences tools company offering ELISA kits, reagents, and assay development services across multiple therapeutic areas including metabolic disease. It competes directly with Mercodia in the immunoassay kit and protein biomarker space and serves overlapping pharma/biotech/academic customers.

TypeDirect peer
Description

ALPCO Diagnostics specializes in immunoassays for metabolic disease research, including insulin, C-peptide, and GLP-1 ELISAs — directly competing with Mercodia's core cardiometabolic product line among academic and pharma researchers.

TypeDirect peer
Description

Cisbio, now part of Revvity, provides HTRF immunoassay technology and bioanalytical kits widely used in drug development for biomarker and PK/PD analysis. It is a direct competitor to Mercodia in pharma-facing ligand binding assays and bioanalytical workflows.

TypeEmerging player
Description

Quanterix offers ultra-sensitive Simoa single-molecule immunoassay technology for biomarker detection. It competes with Mercodia's ultrasensitive ELISA line in research applications requiring extremely low detection limits, particularly in neurology and inflammation research.

TypeBroad incumbent
Description

Sartorius is a major life sciences tools and bioprocessing company with an immunoassay and bioanalytical portfolio serving pharma and biotech. It is a broader incumbent with overlapping customer relationships in bioanalysis and bioprocess analytics.

TypeBroad incumbent
Description

ICON is a top-tier global CRO with extensive bioanalytical and central lab capabilities serving pharma and biotech clinical trials. It competes with Mercodia's bioanalytical services for outsourced clinical sample analysis in cardiometabolic and other programs.

TypeDirect peer
Description

Crystal Chem is a niche direct competitor offering ELISA kits for insulin and metabolic hormones in multiple species (mouse, rat, human). It targets the same academic and pharma research customers as Mercodia and overlaps substantially in product scope.

TypeBroad incumbent
Description

Eurofins is a global leader in bioanalytical CRO services for pharma and biopharma, including PK/PD, immunogenicity, and biomarker analysis — overlapping with Mercodia's services business but at significantly greater scale and across broader therapeutic areas.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mercodia

Immunoassay Kitsmercodia.com

Mercodia is a Swedish biotech founded in 1991 that develops gold-standard immunoassays and provides GLP-compliant bioanalytical services for cardiometabolic drug development, serving pharmaceutical, biotech, and academic customers across 76+ countries.

What Mercodia does

Mercodia is a privately held Swedish biotech company founded in 1991 in Uppsala by Erling Holmlund, formerly of Pharmacia Diagnostics. The company develops and manufactures gold-standard immunoassays—primarily ELISA kits and MBeads bead-based assays—for the quantification of cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, and the more recently launched HNL Homodimer for sepsis research. Its portfolio spans human assays and species-specific kits for mouse, rat, bovine, canine, equine, ovine, and porcine models, complemented by proprietary control and buffer products, and is supported by patented biological assets such as the 4E6 monoclonal antibody underpinning the Oxidized LDL ELISA.

The company operates three revenue streams: (1) immunoassay kit sales distributed across 76+ countries via direct website sales, regional sales managers, and authorized distributors; (2) GLP-compliant bioanalytical services for preclinical and clinical studies—including PK/PD analysis, biomarker analysis across 500+ analytes, assay development, and immunogenicity testing; and (3) ISO 13485:2016 / MDSAP-certified contract manufacturing of reagents, buffers, and coated plates for life science partners. Bioanalytical services are delivered from labs in Uppsala, Sweden and Winston-Salem, North Carolina (established 2023), supporting FDA, EMA, and ICH regulatory workflows for pharmaceutical and biotechnology clients developing diabetes, obesity, and cardiovascular therapies.

Mercodia serves a horizontally segmented customer base spanning pharmaceutical/biotech drug developers, academic and research institutions, and veterinary diagnostics customers, with 9,997+ peer-reviewed publications citing its products and 190+ completed bioanalytical projects. The business has grown approximately 70% over the past three years and 33% in 2024, earning the Di Gasell business growth award from Dagens industri six consecutive times, and is led by CEO Jörgen Dahlström alongside CFO Mats Lundin, CCO Torben Thölix, and COO Jonas Hermansson.

Mercodia firmographics

Firmographics
Name
Mercodia
Legal name
Mercodia Aktiebolag
Website
https://mercodia.com
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
51–100 employees
Short description
Mercodia is a Swedish biotech founded in 1991 that develops gold-standard immunoassays and provides GLP-compliant bioanalytical services for cardiometabolic drug development, serving pharmaceutical, biotech, and academic customers across 76+ countries.
Ownership category
akta.pro rank

Mercodia industry classification

Industry
Product category
Immunoassay Kits
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAEAG
Bioanalytical & PK/PD Sample Analysis (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAHAAAA
Clinical Chemistry & Immunoassay Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Immunoassay kits
  • Bioanalytical services
  • Cardiacmetabolic biomarkers
  • ELISA assays
  • Contract manufacturing

Where Mercodia is headquartered

Location

Headquarters

HQ city
Uppsala
HQ country
Sweden
HQ region
Europe

Offices2 records

Markets served

Mercodia business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Immunoassay Product Sales: Sale of gold-standard ELISA kits and MBeads assays for cardiometabolic research. Products include insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, MPO, HNL Homodimer, and species-specific assays (mouse, rat, bovine, canine, equine, porcine, ovine).
  2. Bioanalytical Services: Contract research services for preclinical and clinical studies including PK/PD analysis, biomarker analysis, assay development, immunogenicity testing. Services provided from GLP-compliant laboratories in Sweden and USA.
  3. Contract Manufacturing: Custom production of assay kits, buffers, coated plates, and key components for life science industry partners. Manufacturing follows ISO 13485:2016 and MDSAP standards.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goStandard ELISA kits - single and 10-pack formats

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Mercodia product offering

Product offering

Core offering

Mercodia develops, manufactures, and sells gold-standard immunoassay kits (ELISA and MBeads platforms) for quantitative measurement of cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, MPO, and HNL Homodimer across human and animal matrices. The company also provides GLP-compliant bioanalytical services (PK/PD, biomarker analysis, assay development, immunogenicity testing) from laboratories in Sweden and the US, and offers contract manufacturing of assay kits and components under ISO 13485:2016 and MDSAP standards.

Product overview

Mercodia offers a comprehensive portfolio of gold-standard immunoassays for cardiometabolic and metabolic disease research, combined with expert bioanalytical services and contract manufacturing solutions. The product portfolio includes over 40 distinct ELISA kits and MBeads assays spanning human, rat/mouse, and larger animal (bovine, canine, equine, ovine, porcine) applications, focused on cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, glicentin, proinsulin, oxidized LDL, Lp(a), MPO, and HNL Homodimer. These are complemented by control products (Diabetes Antigen Controls, GLP-1 Control, Glucagon Control, Animal Insulin Control) and supplement products (Diabetes Sample Buffer). The services division provides GLP-compliant bioanalytical services including PK/PD analysis, biomarker analysis (500+ biomarkers), assay development, immunogenicity testing, and contract manufacturing of assay kits, buffers, and coated plates under ISO 13485:2016 and MDSAP standards.

Differentiator

Problem solved

Functional benefit

Products and services

  • C-peptide ELISA High-quality immunoassay for specific quantification of human C-peptide in serum, plasma, or urine. CE/IVD labeled on selected markets. Measurement range: 100-4000 pmol/L.
  • Ultrasensitive C-peptide ELISA High-quality immunoassay for specific quantification of low levels of human C-peptide in serum, plasma, or urine. Measurement range: 5-280 pmol/L with detection limit below 2.5 pmol/L.
  • Total GIP ELISA Chemiluminescent immunoassay for quantitative determination of total GIP (glucose-dependent insulinotropic polypeptide) in human samples. Measures both active GIP(1-42) and inactive isoform GIP(3-42).
  • Glicentin ELISA Highly specific, sensitive immunoassay for determination of human glicentin in serum, plasma, and cell culture media. No cross-reactivity to circulating proglucagon-derived gut peptides.
  • Total GLP-1 ELISA Chemiluminescent immunoassay for quantitative determination of amidated glucagon-like-peptide-1 (GLP-1) in human plasma and serum. Validated according to CLSI, FDA, and EMA guidelines.
  • Glucagon ELISA CE/IVD-labeled highly specific and sensitive immunoassay for measuring glucagon in plasma and serum. No cross-reactivity to glicentin, proglucagon 1-16, and glucagon 3-29.
  • HNL Homodimer ELISA Immunoassay for specific quantification of human homodimeric Human Neutrophil Lipocalin (HNL) in EDTA plasma. Biomarker for sepsis monitoring and antibiotic response research with superior specificity over CRP and PCT.
  • Insulin (Total) MBeads Assay High-throughput tool enabling high specificity results from small sample volumes. For measurement of insulin in conditioned media from perifusion experiments or in vitro cultures. Kit format: 5 x 96 wells or 1 x 384 wells.
  • Ultrasensitive Insulin ELISA High quality immunoassay for specific quantification of low levels of human insulin in serum or plasma. Measurement range: 0.15-20 mU/L. Calibrated against 1st International Reference Preparation 66/304.
  • Insulin ELISA High-quality ELISA for specific measurement of human insulin in serum or plasma. Measurement range: 3-200 mU/L. Available in 1-pack and 10-pack formats.
  • Insulin MBeads Assay (Human) High-throughput tool for highly specific insulin measurement from minimal sample volumes (10 µL). Optimized for detecting human insulin in serum, conditioned media, cell lysates, and homogenates.
  • Iso-Insulin ELISA Quantitative determination of human insulin in serum or plasma, measuring both endogenous and exogenous insulin including common and non-commercially available insulin analogues.
  • Lispro NL-ELISA Chemiluminescent immunoassay for quantitative determination of insulin lispro. Optimized for pharma use with no cross-reactivity to endogenous insulin or other insulin analogs. Validated for human and pig samples.
  • Lp(a) ELISA Solid phase two-site enzyme immunoassay for quantitative determination of human Lipoprotein(a) in serum or plasma. Calibrated against validated Lp(a) preparation.
  • MPO ELISA High quality enzyme immunoassay for quantification of human myeloperoxidase (MPO) in serum and plasma. Marker for airway inflammation, atherosclerosis, and cardiovascular disease risk.
  • Oxidized LDL ELISA Unique sandwich ELISA based on proprietary mouse monoclonal antibody 4E6 for quantification of oxidized low-density lipoproteins. Central biomarker in atherosclerosis and cardiovascular disease.
  • Proinsulin ELISA Method for quantitative determination of human proinsulin in serum or plasma. Highly specific with no cross-reactivity to human insulin or C-peptide. Calibrated against IRR 84/611.
  • Mouse Insulin ELISA Easy-to-use assay for mouse insulin with highly specific monoclonal antibodies. Measurement range: 0.2-6.5 µg/L. Low sample volume (10 µL with 5 µL protocol available).
  • Bioanalytical Services Tailored bioanalytical services for preclinical to clinical studies, primarily for biologics/large molecules, biosimilars, peptides, and gene therapy products. Includes PK & PD analysis, biomarker analysis, assay development, and immunogenicity testing from GLP-compliant laboratories in Sweden and the US.
  • Biomarker Analysis Biomarker analysis services covering 500+ biomarkers for preclinical and clinical studies in cardiometabolic disease research.
  • PK & PD Analysis Pharmacokinetics and pharmacodynamics analysis services for drug development, providing data to support dosing and efficacy decisions.
  • Immunogenicity Testing Immunogenicity testing services to assess immune responses to biologics and therapeutics, supporting regulatory submissions for large molecule drugs.
  • Assay Development & Optimization Custom assay development and optimization services for specific biomarker and therapeutic analysis needs, leveraging 30+ years of immunoassay expertise.
  • Contract Manufacturing Custom production of assay kits, buffers, coated plates, and key components for the life science industry. Manufacturing validated according to ISO 13485:2016 and MDSAP standards.

Quantifiable outcome

  • 33% revenue growth in 2024, 70% total growth over 3 years
  • +3 more outcomes

Companies that use Mercodia

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles4 records

Mercodia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Mercodia partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Celtic Molecular DiagnosticscoreChannel Partner/ Reseller/ Distributor · 11 March 2026New distribution partnership covering Botswana, Namibia, South Africa, Uganda, and Zambia. Celtic Molecular Diagnostics is a well-established supplier of high-quality laboratory solutions in the region, ensuring improved local availability of Mercodia's immunoassays and responsive customer support.
  • AttanacoreStrategic or Co-development Partner · 24 November 2025Mercodia and Attana entered a strategic collaboration to advance bioanalysis. The partnership combines Mercodia's bioanalytical expertise with Attana's technology to develop next-generation solutions for preclinical drug development.
  • LablyticaminorOthersListed as partner on services page with logo display.
  • SYNLABminorOthersListed as partner on services page with logo display.
  • CTCminorOthersListed as partner on services page with logo display.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Mercodia competitors and assessment

Company assessment

Broad incumbents

  • Charles River Laboratories: Charles River is a large CRO providing preclinical and clinical bioanalytical services, including ligand binding assays and immunogenicity testing. It competes with Mercodia's bioanalytical services arm from a broader portfolio perspective.
  • Sartorius AG: Sartorius is a major life sciences tools and bioprocessing company with an immunoassay and bioanalytical portfolio serving pharma and biotech. It is a broader incumbent with overlapping customer relationships in bioanalysis and bioprocess analytics.
  • ICON plc: ICON is a top-tier global CRO with extensive bioanalytical and central lab capabilities serving pharma and biotech clinical trials. It competes with Mercodia's bioanalytical services for outsourced clinical sample analysis in cardiometabolic and other programs.
  • Eurofins Scientific: Eurofins is a global leader in bioanalytical CRO services for pharma and biopharma, including PK/PD, immunogenicity, and biomarker analysis — overlapping with Mercodia's services business but at significantly greater scale and across broader therapeutic areas.

Direct peers

  • Meso Scale Diagnostics: Meso Scale Diagnostics (MSD) is a direct competitor in high-sensitivity immunoassay platforms for biomarker analysis, serving pharmaceutical, biotech, and academic researchers with multiplexed electrochemiluminescence assays — closely comparable technology and customer base to Mercodia's ELISA and MBeads offerings.
  • Bio-Techne: Bio-Techne is a major life sciences tools company offering ELISA kits, reagents, and assay development services across multiple therapeutic areas including metabolic disease. It competes directly with Mercodia in the immunoassay kit and protein biomarker space and serves overlapping pharma/biotech/academic customers.
  • ALPCO Diagnostics: ALPCO Diagnostics specializes in immunoassays for metabolic disease research, including insulin, C-peptide, and GLP-1 ELISAs — directly competing with Mercodia's core cardiometabolic product line among academic and pharma researchers.
  • Cisbio (Revvity): Cisbio, now part of Revvity, provides HTRF immunoassay technology and bioanalytical kits widely used in drug development for biomarker and PK/PD analysis. It is a direct competitor to Mercodia in pharma-facing ligand binding assays and bioanalytical workflows.
  • Crystal Chem: Crystal Chem is a niche direct competitor offering ELISA kits for insulin and metabolic hormones in multiple species (mouse, rat, human). It targets the same academic and pharma research customers as Mercodia and overlaps substantially in product scope.

Emerging players

  • Quanterix: Quanterix offers ultra-sensitive Simoa single-molecule immunoassay technology for biomarker detection. It competes with Mercodia's ultrasensitive ELISA line in research applications requiring extremely low detection limits, particularly in neurology and inflammation research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Mercodia social profiles

Digital presence

Mercodia compliance and trust

Trust signal

Compliance10 records

Mercodia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mercodia leadership team

Management profile

Number of profiles

Profiles12 records

Mercodia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mercodia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mercodia

What does Mercodia do?

Mercodia develops, manufactures, and sells gold-standard immunoassay kits (ELISA and MBeads platforms) for quantitative measurement of cardiometabolic biomarkers including insulin, C-peptide, glucagon, GLP-1, GIP, oxidized LDL, Lp(a), proinsulin, MPO, and HNL Homodimer across human and animal matrices. The company also provides GLP-compliant bioanalytical services (PK/PD, biomarker analysis, assay development, immunogenicity testing) from laboratories in Sweden and the US, and offers contract manufacturing of assay kits and components under ISO 13485:2016 and MDSAP standards.

Is Mercodia a public or private company?

Mercodia is a private company. It is classified as unknown and is currently operating.

When was Mercodia founded?

Mercodia was founded in 1991. It employs 51 to 100 people.

Where is Mercodia based?

Mercodia is headquartered in Uppsala, Sweden, in the Europe region.

How does Mercodia make money?

Three revenue lines are on record. Immunoassay Product Sales are the primary driver. The others are bioanalytical Services and contract Manufacturing.

Who are Mercodia's main competitors?

Broad incumbents on record are Charles River Laboratories, Sartorius AG, ICON plc and Eurofins Scientific. Direct peers are Meso Scale Diagnostics, Bio-Techne, ALPCO Diagnostics, Cisbio (Revvity) and Crystal Chem. Quanterix is listed as an emerging player.

Does Mercodia have an API?

No public API is recorded for Mercodia.

What industry is Mercodia in?

Mercodia's product category is Immunoassay Kits. Its primary akta.pro industry code is HLAGAEAG, Bioanalytical & PK/PD Sample Analysis (Trial Support), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals